Press Announcements > FDA clears stereotactic radiotherapy system for use in treating breast cancer

Press Announcements > FDA clears stereotactic radiotherapy system for use in treating breast cancer

FDA clears stereotactic radiotherapy system for use in treating breast cancer

		Today, the U.S. Food and Drug Administration cleared a new noninvasive stereotactic radiotherapy system intended for use in treating cancer in breast tissue. Continue reading.